(19)
(11) EP 4 264 269 A1

(12)

(43) Date of publication:
25.10.2023 Bulletin 2023/43

(21) Application number: 21840133.9

(22) Date of filing: 15.12.2021
(51) International Patent Classification (IPC): 
G01N 33/543(2006.01)
G01N 33/58(2006.01)
G01N 33/574(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/54346; G01N 33/57488; G01N 33/587; G01N 33/57407
(86) International application number:
PCT/IB2021/061789
(87) International publication number:
WO 2022/130251 (23.06.2022 Gazette 2022/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 16.12.2020 IT 202000031139

(71) Applicant: Università degli Studi di Roma "La Sapienza"
00185 Roma (IT)

(72) Inventors:
  • CARACCIOLO, Giulio
    00185 Roma (RM) (IT)
  • DI CARLO, Angelina
    00185 Roma (RM) (IT)
  • POZZI, Daniela
    00185 Roma (RM) (IT)
  • DIGIACOMO, Luca
    00185 Roma (RM) (IT)
  • DI SANTO, Riccardo
    00185 Roma (RM) (IT)
  • QUAGLIARINI, Erica
    00185 Roma (RM) (IT)

(74) Representative: Primiceri, Maria Vittoria et al
Praxi Intellectual Property S.p.A. Via Leonida Bissolati, 20
00187 Roma
00187 Roma (IT)

   


(54) SEROLOGICAL TEST TO AID DIAGNOSIS OF GLIOBLASTOMA MULTIFORME